Schering-Plough has been planning this merger for over the last year.  Finally, today the FTC gave the company anti-trust clearance for acquiring Dutch drugmaker Organon BioSciences from Akzo Nobel.  The European Commission gave their approval back in Oct. 11.

Schering-Plough will be acquiring Organon BioSciences for it’s four divisions:   

  • Organon – focusing on human pharmaceutical
  • Intervet – the animal health division
  • Nobilon – human vaccine development unit
  • Diosynth – third-party manufacturing unit

Finalization of the company parts are expected by the end of the year.  The only question now is:  what’s the new company going to be called?  Schering-Plough-Organon?  SPO?  The Schering Group?  SOP?  I just hope it’s not the last one.